Business Description
Nanobiotix SA
NAICS : 325412
SIC : 2834
ISIN : FR0011341205
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.49 | |||||
Equity-to-Asset | -0.02 | |||||
Debt-to-Equity | -27.42 | |||||
Debt-to-EBITDA | -1.68 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.7 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 641.1 | |||||
3-Year EBITDA Growth Rate | 14.2 | |||||
3-Year EPS without NRI Growth Rate | 10.2 | |||||
3-Year FCF Growth Rate | 32.6 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48.58 | |||||
9-Day RSI | 47.46 | |||||
14-Day RSI | 45.65 | |||||
6-1 Month Momentum % | -5.63 | |||||
12-1 Month Momentum % | 214.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.75 | |||||
Quick Ratio | 1.75 | |||||
Cash Ratio | 1.51 | |||||
Days Sales Outstanding | 8.48 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11 | |||||
Shareholder Yield % | -1.23 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -89.09 | |||||
Net Margin % | -132.08 | |||||
FCF Margin % | -42.63 | |||||
ROA % | -61.37 | |||||
ROIC % | -86.47 | |||||
ROC (Joel Greenblatt) % | -477.46 | |||||
ROCE % | -168.04 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.03 | |||||
EV-to-EBIT | -7.34 | |||||
EV-to-EBITDA | -7.7 | |||||
EV-to-Revenue | 7.71 | |||||
EV-to-Forward-Revenue | 6.41 | |||||
EV-to-FCF | -18.09 | |||||
Earnings Yield (Greenblatt) % | -13.62 | |||||
FCF Yield % | -4.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Nanobiotix SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 30.058 | ||
EPS (TTM) (€) | -1.08 | ||
Beta | -0.78 | ||
Volatility % | 161 | ||
14-Day RSI | 45.65 | ||
14-Day ATR (€) | 0.226622 | ||
20-Day SMA (€) | 5.49875 | ||
12-1 Month Momentum % | 214.92 | ||
52-Week Range (€) | 1.618 - 10.4 | ||
Shares Outstanding (Mil) | 47.11 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nanobiotix SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nanobiotix SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Nanobiotix SA Frequently Asked Questions
What is Nanobiotix SA(XPAR:NANO)'s stock price today?
When is next earnings date of Nanobiotix SA(XPAR:NANO)?
Does Nanobiotix SA(XPAR:NANO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |